Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Atea Pharmaceuticals Inc (NASDAQ: AVIR) closed at $3.05 up 0.66% from its previous closing price of $3.03. In other words, the price has increased by $0.66 from its previous closing price. On the day, 0.2 million shares were traded. AVIR stock price reached its highest trading level at $3.07 during the session, while it also had its lowest trading level at $3.01.
Ratios:
For a deeper understanding of Atea Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.66 and its Current Ratio is at 16.66. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for the company, Morgan Stanley on August 13, 2024, Upgraded its rating to Equal-Weight and sets its target price to $6.88 from $2 previously.
Morgan Stanley Downgraded its Equal-Weight to Underweight on January 06, 2022, whereas the target price for the stock was revised from $14 to $7.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 10 ’24 when BERGER FRANKLIN M sold 359,606 shares for $2.85 per share. The transaction valued at 1,023,475 led to the insider holds 451,897 shares of the business.
Franklin Berger bought 359,606 shares of AVIR for $1,023,475 on Dec 10 ’24.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVIR now has a Market Capitalization of 238286736 and an Enterprise Value of -89977272.
Stock Price History:
The Beta on a monthly basis for AVIR is 0.17, which has changed by -0.11403507 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, AVIR has reached a high of $4.02, while it has fallen to a 52-week low of $2.45. The 50-Day Moving Average of the stock is -1.50%, while the 200-Day Moving Average is calculated to be -3.72%.
Shares Statistics:
For the past three months, AVIR has traded an average of 376.59K shares per day and 539990 over the past ten days. A total of 78.13M shares are outstanding, with a floating share count of 62.36M. Insiders hold about 20.18% of the company’s shares, while institutions hold 65.03% stake in the company. Shares short for AVIR as of 1763078400 were 6855045 with a Short Ratio of 18.20, compared to 1760486400 on 6051471. Therefore, it implies a Short% of Shares Outstanding of 6855045 and a Short% of Float of 11.3000005.
Earnings Estimates
. The current market rating for Atea Pharmaceuticals Inc (AVIR) reflects the collective analysis of 2.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.53 and low estimates of -$0.53.
Analysts are recommending an EPS of between -$1.55 and -$1.9 for the fiscal current year, implying an average EPS of -$1.73. EPS for the following year is -$1.75, with 2.0 analysts recommending between -$1.59 and -$1.9.
